Preliminary results of a randomized multicenter controlled trial comparing interferon (IFN) thrice weekly in combination with ribavirin (RBV) with interferon daily in combination with ribavirin and amantadine (AMA) in the treatment of chronic hepatitis C in human immune deficiency virus (HIV) co-infected patients.

被引：0
|
作者：
Puoti, M
Zanini, B
Quinizan, P
Santantonio, T
Cavaliere, R
Roldan, EQ
Castelli, F
Suter, F
Pastore, G
Carosi, G
机构：
[1] Univ Brescia, AO Spedali Civili Brescia, MaSTer HIV HCV Coinfect Study Grp, Brescia, Italy
[2] Osped Riuniti Bergamo, Div Malattie Infett, I-24100 Bergamo, Italy
[3] Univ Bari, Clin Malattie Infett, Bari, Italy
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1692
引用
下载
收藏
页码：586A / 586A
页数：1
相关论文
共 50 条
  • [1] Daily vs. thrice weekly interferon (IFN)in combination with ribavirin (Riba) for patients with chronic hepatitis C infection: Preliminary results of a multicenter randomized trial.
    Kumar, KS
    Brown, M
    Cerulli, M
    Leevy, C
    Moskowitz, S
    Brown, RS
    GASTROENTEROLOGY, 2001, 120 (05) : A571 - A571
  • [2] Combination treatment with interferon (IFN) and ribavirin (RBV) for hepatitis C (HCV) in HIV co-infection patients.
    Dieterich, DT
    Weisz, KB
    Goldman, DJ
    Malicdem, ML
    HEPATOLOGY, 1999, 30 (04) : 266A - 266A
  • [3] Human immune deficiency virus (HIV) co-infection impairs responsiveness to interferon (IFN) and ribavirin (RBV) combination in patients with chronic hepatitis C: Preliminary results of a comparative study.
    Puoti, M
    Barbara, Z
    Paolo, Q
    Santantonio, T
    Cavaliere, R
    Castelli, F
    Serena, Z
    Roldan, EQ
    Suter, F
    Pastore, G
    Carosi, G
    HEPATOLOGY, 2002, 36 (04) : 289A - 289A
  • [4] Treatment of chronic Hepatitis C with pegylated interferon and ribavirin in HIV co-infected patients.
    Hopkins, S
    Hennessy, M
    Lyons, F
    Mulachy, F
    Bergin, C
    HEPATOLOGY, 2002, 36 (04) : 231A - 231A
  • [5] A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C
    Gramenzi, Annagiulia
    Andreone, Pietro
    Cursaro, Carmela
    Verucchi, Gabriella
    Boccia, Sergio
    Giacomoni, Pier Luigi
    Galli, Silvia
    Furlini, Giuliano
    Biselli, Maurizio
    Lorenzini, Stefania
    Attard, Luciano
    Bonvicini, Fiorenza
    Bernardi, Mauro
    JOURNAL OF GASTROENTEROLOGY, 2007, 42 (05) : 362 - 367
  • [6] A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C
    Annagiulia Gramenzi
    Pietro Andreone
    Carmela Cursaro
    Gabriella Verucchi
    Sergio Boccia
    Pier Luigi Giacomoni
    Silvia Galli
    Giuliano Furlini
    Maurizio Biselli
    Stefania Lorenzini
    Luciano Attard
    Fiorenza Bonvicini
    Mauro Bernardi
    Journal of Gastroenterology, 2007, 42 : 362 - 367
  • [7] The preliminary efficacy of interferon-α and ribavirin combination treatment of chronic hepatitis C in HIV-infected patients
    ZHENG Yuhuang ZHANG Chunying HE Yan ZHOU Huaying ZOU Wen DING Peipei HUANG Li and LI Hui AIDS Research Laboratory Division of Infectious Diseases the Second Xiangya Hospital Central South University Hunan Province Changsha China
    Chinese Medical Journal, 2005, (14) : 1195 - 1200
  • [8] The preliminary efficacy of interferon-α and ribavirin combination treatment of chronic hepatitis C in HIV-infected patients
    Zheng, YH
    Zhang, CY
    He, Y
    Zhou, HY
    Zou, W
    Ding, PP
    Huang, L
    Li, H
    CHINESE MEDICAL JOURNAL, 2005, 118 (14) : 1195 - 1200
  • [9] The preliminary efficacy of interferon-α and ribavirin combination treatment of chronic hepatitis C in HIV-infected patients
    ZHENG Yu-huang
    中华医学杂志(英文版), 2005, (14) : 1195 - 1200
  • [10] Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: A multicenter randomized controlled trial
    Sulkowski, MS
    Felizarta, F
    Smith, C
    Slim, J
    Berggren, R
    Goodman, R
    Ball, L
    Khalili, M
    Dieterich, DT
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (05) : 464 - 472
12345